These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31485993)

  • 1. The Design and Application of an Appropriate Parkinson's Disease Animal Model in Regenerative Medicine.
    Larijani B; Goodarzi P; Payab M; Tayanloo-Beik A; Sarvari M; Gholami M; Gilany K; Nasli-Esfahani E; Yarahmadi M; Ghaderi F; Arjmand B
    Adv Exp Med Biol; 2021; 1341():89-105. PubMed ID: 31485993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative Therapies for Parkinson's Disease: An Update.
    Stoker TB; Barker RA
    BioDrugs; 2018 Aug; 32(4):357-366. PubMed ID: 30027398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.
    Arenas E
    J Mol Cell Biol; 2014 Feb; 6(1):42-53. PubMed ID: 24431302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of Alzheimer's Disease Animal Model for the Purpose of Regenerative Medicine.
    Goodarzi P; Payab M; Alavi-Moghadam S; Larijani B; Rahim F; Bana N; Sarvari M; Adibi H; Foroughi Heravani N; Hadavandkhani M; Arjmand B
    Cell Tissue Bank; 2019 Jun; 20(2):141-151. PubMed ID: 31087217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative medicine for Parkinson's disease using differentiated nerve cells derived from human buccal fat pad stem cells.
    Takahashi H; Ishikawa H; Tanaka A
    Hum Cell; 2017 Apr; 30(2):60-71. PubMed ID: 28210976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regenerative medicine for Parkinson's disease.
    Yasuhara T; Kameda M; Agari T; Date I
    Neurol Med Chir (Tokyo); 2015; 55(2):113-23. PubMed ID: 25746305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental modeling of preclinical and clinical stages of Parkinson's disease.
    Khaindrava VG; Kozina EA; Kudrin VS; Kucheryanu VG; Klodt PD; Narkevich VB; Bocharov EV; Nanaev AK; Kryzhanovsky GN; Raevskii KS; Ugrumov MV
    Bull Exp Biol Med; 2011 Mar; 150(5):566-9. PubMed ID: 22235385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
    Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of mouse models of Parkinson's disease.
    Bobela W; Zheng L; Schneider BL
    Curr Protoc Mouse Biol; 2014 Sep; 4(3):121-39. PubMed ID: 25723963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
    Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classic and evolving animal models in Parkinson's disease.
    Pingale T; Gupta GL
    Pharmacol Biochem Behav; 2020 Dec; 199():173060. PubMed ID: 33091373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease and primate research: past, present, and future.
    Pereira EA; Aziz TZ
    Postgrad Med J; 2006 May; 82(967):293-9. PubMed ID: 16679465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
    Kikuchi T; Morizane A; Doi D; Magotani H; Onoe H; Hayashi T; Mizuma H; Takara S; Takahashi R; Inoue H; Morita S; Yamamoto M; Okita K; Nakagawa M; Parmar M; Takahashi J
    Nature; 2017 Aug; 548(7669):592-596. PubMed ID: 28858313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ophthalmic disorders as a manifestation of Parkinson's disease].
    Chesnokova NB; Pavlenko TA; Ugrumov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):124-131. PubMed ID: 29053133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Parkinson's disease : what's on the horizon?
    Wu SS; Frucht SJ
    CNS Drugs; 2005; 19(9):723-43. PubMed ID: 16142989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.